{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":466,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":466,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"685268ecd29a","filters":{"venue":"Haematologica"}},"results":[{"id":"W2157045826","doi":"10.3324/haematol.2008.001743","title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":430,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Genentech; Ipsen; American Heart Association; Novo Nordisk; Grifols; Bayer HealthCare","keywords":"Medicine; Intensive care medicine; Rituximab; Coagulation; Prothrombin complex concentrate; Autoantibody; Coagulopathy; Recombinant factor VIIa; Factor IX; Pediatrics; Internal medicine; Warfarin; Immunology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.06138028311368417,"gpt":0.3259829226792968,"spread":0.2646026395656127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003422745,0.00008472564,0.0001731079,0.00005361606,0.0000684262,0.000008053006,0.00004501275,0.00003398712,0.000389425],"category_scores_gemma":[0.00004979026,0.00003560031,0.00003571488,0.00008012217,0.00007148127,0.00002186909,0.000009112937,0.00002484771,0.00001176489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003464078,"about_ca_system_score_gemma":0.00001296153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003226474,"about_ca_topic_score_gemma":0.000001318041,"domain_scores_codex":[0.9994671,0.00002748189,0.0001115956,0.0001315144,0.0001613086,0.0001009632],"domain_scores_gemma":[0.9995445,0.0001510574,0.00004137306,0.0001496371,0.00006419269,0.00004920987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001073126,0.004355967,0.8697253,0.00001027978,0.000232201,0.0000712038,0.0004657517,4.069093e-7,0.00004520712,0.004911117,0.002931018,0.1161785],"study_design_scores_gemma":[0.003162156,0.006768349,0.9710118,0.0001039503,0.00007404012,0.00002105061,0.00009759305,0.00002867104,0.003900235,0.0004957566,0.01425221,0.00008425682],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9472169,0.00003829357,0.000001446033,0.04646572,0.00002040284,0.0004740072,0.0000152806,0.00001605389,0.005751939],"genre_scores_gemma":[0.9984897,0.0004752127,0.0003168522,0.0002672801,0.00001545766,0.00006928146,0.00005251669,0.000003376372,0.0003102707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1160942,"threshold_uncertainty_score":0.426393,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147758514","doi":"10.3324/haematol.2009.010264","title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Instituto de Salud Carlos III; Julius-Maximilians-Universität Würzburg","keywords":"Mantle cell lymphoma; Cyclin D1; Cancer research; Lymphoma; BCL10; Biology; Cyclin D2; Pathology; Medicine; Cell; Cell cycle; Immunology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02537569048473817,"gpt":0.2710360779570358,"spread":0.2456603874722977,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000877424,0.0001847494,0.0003627872,0.0000412461,0.000235906,0.00005190217,0.00009087946,0.0001057085,0.0001139488],"category_scores_gemma":[0.0000444199,0.00009652131,0.0001156497,0.00008046292,0.000100895,0.00005638383,0.00003779359,0.00003885823,0.00009361617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003898825,"about_ca_system_score_gemma":0.00002410283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001348298,"about_ca_topic_score_gemma":0.000003289735,"domain_scores_codex":[0.9989875,0.0000358274,0.0002318002,0.0003401194,0.0001627862,0.0002419602],"domain_scores_gemma":[0.9991141,0.0003088922,0.0001146222,0.0003170132,0.00006087042,0.00008448202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003764696,0.007997562,0.05539913,0.0005636315,0.0003408143,0.001959229,0.008570842,0.000001731866,0.05063878,0.0186317,0.7854276,0.06670427],"study_design_scores_gemma":[0.006113937,0.0009516921,0.2354358,0.0001980852,0.0001666287,0.0002937433,0.001044568,0.00003397277,0.7162187,0.01027024,0.02902435,0.0002483079],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860298,0.002633503,0.00003683289,0.005595471,0.0001561785,0.0007939684,0.00002149081,0.00006468784,0.004668078],"genre_scores_gemma":[0.9951396,0.001024103,0.001237064,0.001189201,0.00006663938,0.00009462278,0.00001585689,0.00001016997,0.001222724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7564033,"threshold_uncertainty_score":0.3936025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3021433538","doi":"10.3324/haematol.2019.230771","title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Partial thromboplastin time; Autoantibody; Rituximab; Cyclophosphamide; Internal medicine; Recombinant factor VIIa; Factor IX; Coagulation; Prothrombin time; Immunology; Gastroenterology; Antibody; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1513120129974629,"gpt":0.3605846803956029,"spread":0.20927266739814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003736937,0.00007634777,0.000187702,0.00003007282,0.00005894412,0.000007952478,0.00005496406,0.00003720489,0.001103582],"category_scores_gemma":[0.0001586917,0.00003643026,0.00005885972,0.00008812614,0.00008598899,0.00001578598,0.00002701442,0.00002271031,0.00004846241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002239067,"about_ca_system_score_gemma":0.00001586015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005383986,"about_ca_topic_score_gemma":8.580849e-7,"domain_scores_codex":[0.9994795,0.00003630726,0.0001270384,0.0001416795,0.0001257104,0.00008977056],"domain_scores_gemma":[0.9994792,0.0002589389,0.00003457816,0.000113159,0.00003486408,0.00007925614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002442535,0.005247166,0.60127,0.0001663027,0.001612169,0.0009502353,0.006987702,0.000002391399,0.004750073,0.03501547,0.06644088,0.275115],"study_design_scores_gemma":[0.01020622,0.01677562,0.1371073,0.0004084255,0.0004524724,0.0003960912,0.002489574,0.001940405,0.1642854,0.001751222,0.6637168,0.0004704511],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.707924,0.0001047768,0.000002859314,0.284606,0.00002839375,0.0003387043,0.00001411509,0.00002147007,0.006959629],"genre_scores_gemma":[0.9966277,0.001808867,0.0002850988,0.0008080825,0.00004627958,0.0001213022,0.00002282542,0.000004681812,0.0002751331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5972759,"threshold_uncertainty_score":0.9998096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099825600","doi":"10.3324/haematol.2009.017079","title":"PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Gertrude von Meissner-Stiftung; Karolinska Institutet; VINNOVA; Novartis Foundation; Krebsliga Beider Basel; Stiftelsen för Strategisk Forskning; Knut och Alice Wallenbergs Stiftelse; National Research Foundation; Genome Canada; GlaxoSmithKline; Ontario Innovation Trust; Wellcome Trust","keywords":"PIM1; Kinase; Biology; Cancer research; AKT3; Kinome; Serine; Threonine; Cell biology; Phosphorylation","retraction":null,"screen_n_in":null,"score":{"opus":0.06871072317786502,"gpt":0.3507607535035781,"spread":0.2820500303257131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003581909,0.0004476992,0.002642023,0.0001618966,0.00007411536,0.00002285416,0.0002008991,0.0004160281,0.000103149],"category_scores_gemma":[0.00005804022,0.0002261584,0.0002241921,0.0002964577,0.0003692231,0.00003064733,0.00006622908,0.0003782788,0.000001916279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002644515,"about_ca_system_score_gemma":0.0002018711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009310497,"about_ca_topic_score_gemma":0.0001081514,"domain_scores_codex":[0.998281,0.0001445511,0.0006047971,0.0004571426,0.0002039721,0.0003085607],"domain_scores_gemma":[0.9987445,0.0002541128,0.0003977073,0.0004772518,0.00005299504,0.00007342169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001533098,0.0001818457,0.0003708311,0.01297559,0.0001684444,0.000886921,0.0004204006,1.126686e-7,0.0003921875,0.005711666,0.0001611555,0.9785776],"study_design_scores_gemma":[0.001306259,0.001087575,0.000696387,0.008771162,0.0003828457,0.01051673,0.0003108591,0.00000325257,0.000374545,0.001194353,0.9748265,0.0005294895],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03379299,0.9644004,0.000006404425,0.0002440165,0.0001001735,0.001238528,0.00004043333,0.00003143604,0.0001455728],"genre_scores_gemma":[0.007811766,0.9909807,0.0003443258,0.0003658236,0.0000471004,0.0003669658,0.00001996022,0.00003239317,0.00003099215],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.978048,"threshold_uncertainty_score":0.922247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098388627","doi":"10.3324/haematol.10937","title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":350,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Hospital for Sick Children; U.S. Public Health Service; Wellcome Trust","keywords":"Medicine; Pediatrics; Interquartile range; Cohort; Sepsis; Pneumococcal conjugate vaccine; Thalassemia; Confidence interval; Transcranial Doppler; Sickle cell anemia; Streptococcus pneumoniae; Internal medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.009462221804418917,"gpt":0.2644916594530172,"spread":0.2550294376485983,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008126509,0.0002021205,0.0006736567,0.0002309191,0.00002734188,0.000008992359,0.0001099164,0.0002327386,0.00007632759],"category_scores_gemma":[0.000355952,0.0001320491,0.00009346374,0.0003596068,0.0001286741,0.00005342083,0.00006784748,0.0006274645,0.00003641842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004916217,"about_ca_system_score_gemma":0.00008969734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003639318,"about_ca_topic_score_gemma":0.001457922,"domain_scores_codex":[0.9981655,0.0001017492,0.0006323453,0.0004044763,0.0002180919,0.0004778075],"domain_scores_gemma":[0.9991567,0.0002416505,0.00009219128,0.0002580124,0.00001930099,0.0002321691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004850476,0.0009070371,0.9924617,0.00003803571,0.00002327905,0.002740314,0.000419646,0.00002136262,0.000001403163,0.00002681179,0.00001402319,0.002861362],"study_design_scores_gemma":[0.004263788,0.0002087977,0.9942207,0.0002775744,0.00003484523,0.0001744628,0.0003408862,0.00008711944,0.000005865879,0.0000336241,0.0001745735,0.0001777512],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969037,0.0007980284,0.00003968129,0.0003501386,0.00005131542,0.0007637917,0.000003713278,0.00005255071,0.00103711],"genre_scores_gemma":[0.9988906,0.0002192025,0.0002968313,0.0004004184,0.0000192625,0.00002042266,0.00002017892,0.00001787392,0.0001152237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003778741,"threshold_uncertainty_score":0.5384808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161021913","doi":"10.3324/haematol.2014.115840","title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Stanford Cancer Institute; National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; University of California, Los Angeles; Monash University; Hollings Cancer Center, Medical University of South Carolina; Northwestern University; Incyte; NIH Clinical Center; Townsville Hospital and Health Service; Emory University; Huntsman Cancer Institute; University of Toronto; Tower Cancer Research Foundation; London Health Sciences Centre; Barbara Ann Karmanos Cancer Institute; Rush University; University of Louisville; Georgetown University; National Cancer Institute; Wake Forest University; Kaiser Permanente; Cleveland Clinic; George Washington University; University of Pennsylvania; Vanderbilt University; University of Southern California; Park Nicollet Foundation","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Surgery; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.02592074123617636,"gpt":0.2561980427566157,"spread":0.2302773015204394,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471001,0.0002138635,0.0009332069,0.0001138981,0.00002630321,0.000005878685,0.00006888874,0.00009999642,0.00002128151],"category_scores_gemma":[0.0002445794,0.0001213314,0.00004175361,0.0002340451,0.0002318813,0.00004763173,0.00005050325,0.0001054879,0.000004374324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003497523,"about_ca_system_score_gemma":0.0001222909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001723386,"about_ca_topic_score_gemma":0.0004300684,"domain_scores_codex":[0.998366,0.00009325219,0.0005138778,0.0003184558,0.0004615191,0.0002468866],"domain_scores_gemma":[0.9987329,0.0002432088,0.0002630363,0.0002907601,0.0002550115,0.0002150483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02487208,0.0009852959,0.9709768,0.0001031196,0.0001521903,0.00008672645,0.0009409885,0.00000422202,0.000003276826,0.001044774,0.0001740491,0.0006565365],"study_design_scores_gemma":[0.04756032,0.006610047,0.9425319,0.0007102885,0.0001415655,0.00003315861,0.0005540156,0.000008781849,0.001383675,0.00004838272,0.0002692839,0.0001486013],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939588,0.00007313224,0.000007690863,0.0003938855,0.00003638211,0.0008362248,0.00009902887,0.00002062882,0.004574178],"genre_scores_gemma":[0.9978845,0.00006175807,0.001786823,0.00003281255,0.000009205371,0.00003554472,0.0001194268,0.00001626872,0.00005368002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02844487,"threshold_uncertainty_score":0.494775,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2907285051","doi":"10.3324/haematol.2018.209114","title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":322,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Universitätsklinikum Köln; Tianjin Medical University; University College London Hospitals NHS Foundation Trust; Medizinische Universität Wien; National and Kapodistrian University of Athens; Università degli Studi di Roma Tor Vergata; Universitair Medisch Centrum Groningen; Cleveland Clinic; University College London; University of Toronto; University of Oklahoma Health Sciences Center; Universität Wien; Cardiff University; University of Washington; University of Oklahoma; Samsung; Pusan National University; University of Ottawa; Ohio State University","keywords":"Medicine; Ambulatory; Internal medicine; Incidence (geometry); Framingham Risk Score; Meta-analysis; Venous thromboembolism; Thrombosis; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.1674165448168712,"gpt":0.3819672575359277,"spread":0.2145507127190565,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009199735,0.0004737205,0.01788292,0.0002842105,0.0000967728,0.00002544865,0.000279449,0.0002410578,0.00008558208],"category_scores_gemma":[0.0003810576,0.0002230752,0.002400628,0.000757108,0.00009622343,0.0000425509,0.0001145065,0.0002086271,0.000008166454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009720891,"about_ca_system_score_gemma":0.0001043668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007467785,"about_ca_topic_score_gemma":0.00006736792,"domain_scores_codex":[0.9966407,0.0003319582,0.001793443,0.0005549333,0.0003484054,0.000330572],"domain_scores_gemma":[0.9968723,0.0005606253,0.001418595,0.0008562436,0.0002220862,0.00007015115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00000314362,0.0004119015,0.00001177851,0.8904979,0.1056359,0.000003633916,0.00003991283,4.819272e-7,3.352126e-9,0.0006181677,0.001068195,0.001708992],"study_design_scores_gemma":[0.0001994326,0.0002998425,0.0001414113,0.07073305,0.8999673,0.000009522507,0.00001786831,0.000004679791,7.112517e-8,0.00004011246,0.02842754,0.0001591901],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000107945,0.982436,0.00001118472,0.0002322434,0.00008568964,0.01656167,0.0004922864,0.00002371842,0.0001464347],"genre_scores_gemma":[0.0001909586,0.9912673,0.00003824366,0.000361214,0.00001254371,0.007743752,0.0002080834,0.00003666762,0.0001412638],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8197649,"threshold_uncertainty_score":0.9966976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2739393823","doi":"10.3324/haematol.2017.171041","title":"Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Medicine; Internal medicine; Discontinuation; Mantle cell lymphoma; Atrial fibrillation; Cumulative incidence; Adverse effect; Chronic lymphocytic leukemia; Hazard ratio; Oncology; Confidence interval; Leukemia; Lymphoma; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.08473874912293827,"gpt":0.384229192574077,"spread":0.2994904434511387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006915556,0.0001581445,0.003025692,0.0001701264,0.0001045504,0.00001678625,0.0001281772,0.0002371033,0.000197024],"category_scores_gemma":[0.04776195,0.000105142,0.0006761196,0.00009300716,0.0001909155,0.000166791,0.00005136739,0.0001091803,0.00001551919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006649146,"about_ca_system_score_gemma":0.001564169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002531418,"about_ca_topic_score_gemma":0.00002137134,"domain_scores_codex":[0.9959578,0.0009116168,0.002099273,0.0003002155,0.0005139425,0.0002171649],"domain_scores_gemma":[0.9948905,0.001222743,0.002873622,0.000714222,0.0002267787,0.00007219461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9573528,0.00009152105,0.008079634,0.0002953672,0.0006643411,0.0004372099,0.0002511647,0.00004634651,0.02932263,0.001826179,0.00004911648,0.001583732],"study_design_scores_gemma":[0.965139,0.000133724,0.01108166,0.0003223263,0.0004102479,0.0002504404,0.00002113143,0.01571614,0.006076631,0.0005711702,0.0001568047,0.0001206753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912586,0.00007046918,0.000273268,0.0007693705,0.000255117,0.004833202,0.000006076125,0.00003632193,0.002497541],"genre_scores_gemma":[0.9983,0.0003008815,0.0002420448,0.00001698706,0.0001988872,0.00006377079,0.0001485709,0.00001114223,0.0007177105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04084639,"threshold_uncertainty_score":0.9602591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126532431","doi":"10.3324/haematol.2014.119545","title":"A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Ruxolitinib; Medicine; Hazard ratio; Internal medicine; Myelofibrosis; Placebo; Survival analysis; Confidence interval; Crossover study; Proportional hazards model; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1259945300572344,"gpt":0.3900717844310114,"spread":0.2640772543737769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002040311,0.0002578518,0.005087342,0.0002908129,0.00005053233,0.000006427245,0.00007583545,0.0001155578,0.0001232198],"category_scores_gemma":[0.001035574,0.0001260024,0.0008786019,0.000353648,0.0003031916,0.00003005739,0.00003119223,0.00004057908,1.893991e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000529614,"about_ca_system_score_gemma":0.0001099153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006229859,"about_ca_topic_score_gemma":0.0001942019,"domain_scores_codex":[0.9970554,0.0004593081,0.001688351,0.0002775105,0.0002979438,0.0002215457],"domain_scores_gemma":[0.9932458,0.005097935,0.0009632641,0.0003499198,0.0002207142,0.0001223371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6767585,0.02320636,0.1819709,0.0005704511,0.05021477,0.00008517459,0.01189435,0.00032686,0.00140334,0.04175377,0.000591236,0.0112243],"study_design_scores_gemma":[0.8975375,0.01012181,0.01262134,0.0002359703,0.03451324,0.00002132586,0.001360991,0.007119356,0.03383325,0.001330959,0.001043346,0.0002609129],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918848,0.002806047,0.0003015029,0.0005937257,0.00005054502,0.003573129,0.0004096933,0.00001129509,0.0003692901],"genre_scores_gemma":[0.9960652,0.001676832,0.001125296,0.00004673903,0.00001619307,0.0008026774,0.0001818054,0.0000100317,0.000075212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.220779,"threshold_uncertainty_score":0.5138227,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2292251821","doi":"10.3324/haematol.2015.137380","title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Asparaginase; Medicine; Lymphoblastic Leukemia; Antibody; Immunology; Intensive care medicine; Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.05685968397073798,"gpt":0.3407853727054265,"spread":0.2839256887346885,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000207453,0.00007253928,0.0001856751,0.00006733814,0.00006027752,0.000006681715,0.00002259472,0.00005109194,0.00001245826],"category_scores_gemma":[0.0001783821,0.00004671151,0.00002069236,0.00006276596,0.0001578543,0.00003855362,0.00004570267,0.00002529958,0.000003602154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008899382,"about_ca_system_score_gemma":0.00002614253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001387952,"about_ca_topic_score_gemma":0.000001398625,"domain_scores_codex":[0.9993334,0.00004124749,0.0001897881,0.0002087975,0.0001076905,0.0001191086],"domain_scores_gemma":[0.9991821,0.0003946762,0.00008907915,0.0001576964,0.0001161047,0.00006032192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003259319,0.0009644303,0.006102022,0.002420024,0.0006404647,0.0003247274,0.001260483,5.879379e-7,0.3976807,0.08202347,0.03530323,0.4700206],"study_design_scores_gemma":[0.02907164,0.002144471,0.3027786,0.003155122,0.0006521264,0.003885255,0.008033942,0.004839957,0.6003988,0.009773438,0.03434733,0.0009192191],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633777,0.0001163872,0.01258022,0.02242102,0.00004164731,0.0008456714,0.0000246448,0.00003181131,0.0005609713],"genre_scores_gemma":[0.9917821,0.000557951,0.007170573,0.0001016752,0.00001011465,0.0001029336,0.00001269735,0.000006440794,0.0002555112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4691013,"threshold_uncertainty_score":0.190484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4229065705","doi":"10.3324/haematol.2021.279189","title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","year":2021,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Core Research for Evolutional Science and Technology; Universitätsspital Basel","keywords":"Latin Americans; Transplantation; Population; Hematopoietic cell; Medicine; Demography; Internal medicine; Haematopoiesis; Stem cell; Political science; Biology; Environmental health; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0360581968105048,"gpt":0.2567178585938418,"spread":0.220659661783337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001383745,0.0002204259,0.0007331842,0.0001015588,0.00005866901,0.00007371754,0.00009361086,0.0001251835,0.00003380909],"category_scores_gemma":[0.000009963857,0.0001428907,0.00005434467,0.0002380982,0.0002197902,0.0001086672,0.00005160445,0.0002094754,0.000002110252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001712726,"about_ca_system_score_gemma":0.00005398869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001596797,"about_ca_topic_score_gemma":0.0002624994,"domain_scores_codex":[0.9983323,0.0001038941,0.0005325295,0.0004129619,0.0003280847,0.0002902716],"domain_scores_gemma":[0.9989982,0.0003753782,0.0001425974,0.0002812663,0.00008324645,0.0001193001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005039939,0.003414634,0.4354247,0.01831341,0.000637002,0.007262282,0.01448003,0.00003057008,0.5029411,0.001564774,0.0002479994,0.01064353],"study_design_scores_gemma":[0.01266403,0.001265108,0.5354342,0.004274813,0.001373786,0.002713916,0.004307656,0.00102896,0.436001,0.0001273737,0.0001420673,0.0006671125],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929619,0.0004090515,0.004714317,0.0008860403,0.00003973285,0.0008033822,0.00001527236,0.00002317814,0.0001471447],"genre_scores_gemma":[0.9979421,0.0007734328,0.0008241897,0.0002443305,0.000008803998,0.00006151275,0.00002169263,0.0000194786,0.0001044843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1000094,"threshold_uncertainty_score":0.5826913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994932701","doi":"10.3324/haematol.2011.055269","title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; U.S. Public Health Service; Bernische Krebsliga; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Dyskeratosis congenita; Telomere; Bone marrow failure; Fluorescence in situ hybridization; Dyskeratosis; Aplastic anemia; Telomerase; Biology; Medicine; Pathology; Genetics; Bone marrow; Hyperkeratosis; Gene; Chromosome; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.04781214776789845,"gpt":0.2463831833964113,"spread":0.1985710356285128,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001409338,0.0003011005,0.0006916853,0.0001295824,0.0001105971,0.00002410036,0.0001139573,0.0001405357,0.0002318171],"category_scores_gemma":[0.0002220873,0.0001887328,0.00004586515,0.0004119116,0.0004091721,0.0001253966,0.00005025618,0.0002528028,0.0000172515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003215224,"about_ca_system_score_gemma":0.0001081241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001374964,"about_ca_topic_score_gemma":0.0008212861,"domain_scores_codex":[0.998417,0.00008694348,0.0002994135,0.0005108,0.0002696968,0.0004161472],"domain_scores_gemma":[0.9989269,0.0001114983,0.0001234125,0.0003642109,0.0001221069,0.0003518896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001380722,0.0004988779,0.9882449,0.000126144,0.0001179869,0.006709523,0.001380892,9.032568e-8,0.00006566555,0.000272909,0.0003033949,0.0008989249],"study_design_scores_gemma":[0.002146861,0.0004450368,0.9940391,0.0003696994,0.0001886,0.000380301,0.0005044431,0.00004435745,0.001044018,0.0002163875,0.0002746574,0.0003465968],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996364,0.0006430625,0.00001424385,0.000523487,0.0000252195,0.0004977256,0.00002900313,0.0001459855,0.001757275],"genre_scores_gemma":[0.9971534,0.0002205259,0.001106193,0.001111211,0.00001447935,0.00005298199,0.00002542058,0.00002718091,0.0002886184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006329223,"threshold_uncertainty_score":0.7696302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2967535150","doi":"10.3324/haematol.2019.221093","title":"Hemophilia A and B: molecular and clinical similarities and differences","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Factor IX; Coagulation; Medicine; Coagulopathy; Gene; Hematology; Genetics; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1948791731206436,"gpt":0.4379213097387315,"spread":0.2430421366180879,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002723582,0.000371093,0.002778529,0.0001260879,0.00007988414,0.00004888089,0.00007555907,0.0005990666,0.00005404298],"category_scores_gemma":[0.0002537373,0.0002027893,0.0002138207,0.00008969623,0.0006211977,0.00002755028,0.0002501775,0.0005113436,0.0000264985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001197884,"about_ca_system_score_gemma":0.0001135411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005108639,"about_ca_topic_score_gemma":0.000001219678,"domain_scores_codex":[0.9981714,0.0002211537,0.0004896387,0.0006094115,0.0002108021,0.0002976308],"domain_scores_gemma":[0.9986258,0.0006669904,0.0001159564,0.0002997583,0.00003630676,0.0002551597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000047996,0.0001771235,0.01532114,0.06405332,0.0006942394,0.002248076,0.00004188263,3.101618e-10,3.858415e-7,0.00198034,0.0004642664,0.9149712],"study_design_scores_gemma":[0.001984463,0.002188324,0.003756783,0.02505183,0.004886115,0.007530595,0.0001115645,0.00001759638,0.000003207684,0.001051273,0.9526274,0.0007908533],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02013952,0.9768437,0.000001233584,0.0005559936,0.00005681095,0.001077126,0.00001676587,0.00004047198,0.001268356],"genre_scores_gemma":[0.002775329,0.9956595,0.0002876248,0.0001102914,0.00004533386,0.00004364407,0.00002881075,0.00002389626,0.001025585],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9521631,"threshold_uncertainty_score":0.8269508,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2890977830","doi":"10.3324/haematol.2018.194282","title":"Daratumumab plus lenalidomide and dexamethasone <i>versus</i> lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary; University of British Columbia; University of Alberta; Queen Elizabeth II Health Sciences Centre; Université Laval; Dalhousie University","funders":"Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Yale University","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Hazard ratio; Multiple myeloma; Internal medicine; Oncology; Confidence interval; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.06103873061989124,"gpt":0.341154983171765,"spread":0.2801162525518738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007639809,0.0004412194,0.001881113,0.000996228,0.0001898662,0.00003880597,0.0001900184,0.000350978,0.0005529944],"category_scores_gemma":[0.00277417,0.0003063928,0.0001891619,0.001859746,0.0009777272,0.0001517646,0.0002435696,0.0004176896,0.00002640261],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001801771,"about_ca_system_score_gemma":0.0002058782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001126983,"about_ca_topic_score_gemma":0.003399629,"domain_scores_codex":[0.9965365,0.0004471402,0.000845135,0.0008777263,0.0005548571,0.0007386734],"domain_scores_gemma":[0.9965798,0.001621591,0.0003485564,0.0007224476,0.0002635043,0.0004640696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2077887,0.002769164,0.6884001,0.000763532,0.01258291,0.007166279,0.003129892,0.00002584353,0.04540213,0.0005845175,0.002377513,0.02900947],"study_design_scores_gemma":[0.1186279,0.006893391,0.7977716,0.0005640023,0.004828904,0.0008006648,0.002358753,0.01791076,0.04619798,0.0001453517,0.002780054,0.001120621],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955787,0.001545287,0.0001343307,0.000439379,0.00007670138,0.0008643709,0.00009322684,0.00008542723,0.001182563],"genre_scores_gemma":[0.9904757,0.000562291,0.008133018,0.0001639388,0.00004133337,0.00006844001,0.0001416744,0.00003664635,0.0003769275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1093715,"threshold_uncertainty_score":0.9999388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108495564","doi":"10.3324/haematol.2010.030296","title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Universität Heidelberg; Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Multiple myeloma; Beta-2 microglobulin; Internal medicine; Oncology; Cancer research; Medicine; Chemotherapy; Proliferation index; Hematology; Bone marrow; Biology; Immunohistochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04033096311217572,"gpt":0.3031161525604666,"spread":0.2627851894482909,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000857098,0.0002081226,0.0004165571,0.0001041975,0.0001399261,0.00003928213,0.00003506438,0.0001553479,0.0001307579],"category_scores_gemma":[0.0006287023,0.0001366079,0.0000603646,0.00006892905,0.0001043847,0.00006465499,0.00002716935,0.0001720407,0.000005916349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005320734,"about_ca_system_score_gemma":0.00008741628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001811008,"about_ca_topic_score_gemma":0.0006879955,"domain_scores_codex":[0.9987167,0.00006017784,0.0002189807,0.0003987536,0.0001870287,0.0004183217],"domain_scores_gemma":[0.9991787,0.0002574776,0.000077128,0.0001469338,0.00006371256,0.0002760627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00139091,0.0005133096,0.9853867,0.00008963038,0.0001214631,0.0001671632,0.00101868,1.522598e-7,0.001734532,0.0001440226,0.0000277679,0.009405619],"study_design_scores_gemma":[0.01218663,0.001462709,0.9717692,0.0000341788,0.0000714059,0.0002614455,0.0001452285,0.006467138,0.005865405,0.0001852619,0.001409389,0.0001420785],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954847,0.0002966777,0.0001436668,0.0005116176,0.00003810915,0.003265698,0.0001657,0.0000469017,0.00004695191],"genre_scores_gemma":[0.9917063,0.0001936959,0.007021147,0.00003763065,0.00003119323,0.0007106111,0.00009780585,0.00001519564,0.0001864828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01361762,"threshold_uncertainty_score":0.5570707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2913806361","doi":"10.3324/haematol.2018.205526","title":"IgG4-related disease: what a hematologist needs to know","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; IgG4-related disease; Retroperitoneal fibrosis; Rituximab; Autoimmune pancreatitis; Lymphoplasmacytic Lymphoma; Lymphoma; Pathology; Disease; Eosinophilia; Bone marrow; Lymphoproliferative disorders; Fibrosis; Hypergammaglobulinemia; Waldenstrom macroglobulinemia","retraction":null,"screen_n_in":null,"score":{"opus":0.05655250605357538,"gpt":0.3491573027939429,"spread":0.2926047967403675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0002805933,0.001309066,0.00595431,0.0009402965,0.000201861,0.0002332614,0.0007086617,0.00130313,0.002172558],"category_scores_gemma":[0.0007561853,0.0008926917,0.001995124,0.001514366,0.0002611537,0.000334562,0.0003967152,0.001081398,0.02001106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002172485,"about_ca_system_score_gemma":0.001037048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003206876,"about_ca_topic_score_gemma":6.094302e-7,"domain_scores_codex":[0.994928,0.00034426,0.001798013,0.00120057,0.0006456623,0.001083495],"domain_scores_gemma":[0.9954062,0.0003836535,0.0007052611,0.001931006,0.0002044762,0.001369387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000363849,0.001003313,0.0002445442,0.1429686,0.001707877,0.009941279,0.000190219,0.000004164355,7.541924e-7,0.0183167,0.1200676,0.7051911],"study_design_scores_gemma":[0.00054285,0.0002247643,0.00002559062,0.07509813,0.00480244,0.002023317,0.0001348444,0.000007136358,0.000001427265,0.0001091831,0.9160984,0.0009319798],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002025941,0.9870087,0.000006561507,0.0008322264,0.001249392,0.004218514,0.00009473106,0.000810107,0.005577177],"genre_scores_gemma":[0.0002459822,0.9881856,0.00009607533,0.0009008946,0.0001373774,0.0005998221,0.0008481038,0.0001871384,0.008798941],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7960307,"threshold_uncertainty_score":0.9999934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161183750","doi":"10.3324/haematol.2010.026989","title":"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors","year":2010,"lang":"en","type":"review","venue":"Haematologica","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; McMaster University","funders":"National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Post-thrombotic syndrome; Medicine; Prospective cohort study; Venous thrombosis; Confidence interval; Internal medicine; Thrombosis; Quality of life (healthcare); Intensive care medicine; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.1075380787791004,"gpt":0.3460268132182917,"spread":0.2384887344391912,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001135225,0.0005421497,0.01010863,0.0004380218,0.0000233236,0.000005144881,0.0003279953,0.0005790841,0.000101839],"category_scores_gemma":[0.003670704,0.0003376812,0.0006853717,0.0006166457,0.0002277582,0.00004955916,0.00009720962,0.0005889207,0.000007198146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002566381,"about_ca_system_score_gemma":0.0002276707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003295857,"about_ca_topic_score_gemma":0.000006924981,"domain_scores_codex":[0.9948623,0.0006276233,0.003183104,0.0004595662,0.0006024944,0.0002649618],"domain_scores_gemma":[0.9955412,0.000538422,0.002628491,0.0008313276,0.000323639,0.0001369134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000001176336,0.0003447273,0.0208777,0.9766815,0.0002536474,0.00002288395,0.00002164614,4.210652e-9,0.000004449887,0.001200837,0.000002096371,0.000589324],"study_design_scores_gemma":[0.0003517357,0.00057296,0.0127917,0.9740265,0.009245142,0.002450225,0.00001364292,4.050078e-7,0.00001984886,0.0001433129,0.00004664134,0.000337876],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01307118,0.9802784,0.00001160369,0.00001516362,0.0001111629,0.006153325,0.0002682653,0.00003217437,0.00005871294],"genre_scores_gemma":[0.1276414,0.8716692,0.0003109044,0.00002698374,0.000003343501,0.0001311144,0.0001892377,0.00002377419,0.000004089619],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1145702,"threshold_uncertainty_score":0.9999075,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2462762289","doi":"10.3324/haematol.2016.148809","title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Medicine; Oncology; Classical Hodgkin lymphoma; Hodgkin's lymphoma; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07290797828020769,"gpt":0.3391449359009706,"spread":0.2662369576207629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005808541,0.0002544314,0.0005876577,0.0001285279,0.00009662547,0.00002978542,0.0004937312,0.00009045625,0.0001811118],"category_scores_gemma":[0.0005884716,0.0001021836,0.0001818188,0.0004928054,0.0001508078,0.00009284351,0.000111703,0.00004475337,0.000102737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003397326,"about_ca_system_score_gemma":0.0003808835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006142946,"about_ca_topic_score_gemma":0.0003042492,"domain_scores_codex":[0.9979533,0.0001729242,0.0006957331,0.0004194475,0.0004900077,0.000268582],"domain_scores_gemma":[0.9973337,0.00145664,0.0003760488,0.0006427449,0.0001509142,0.00003992805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000578972,0.002238906,0.5245442,0.001088272,0.0005403545,0.00181379,0.0013188,1.563587e-7,0.0008942356,0.01320012,0.09306809,0.3607141],"study_design_scores_gemma":[0.003554696,0.0001814461,0.9174832,0.01225236,0.0001761509,0.0007508812,0.0004119271,0.00003416021,0.003701644,0.000342492,0.06089539,0.0002157015],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9359936,0.007179996,0.0001288381,0.04674677,0.0002991437,0.002045946,0.000071098,0.0000524705,0.007482106],"genre_scores_gemma":[0.9823728,0.01053219,0.001261777,0.004845577,0.0001069998,0.0006635276,0.00006720057,0.0000162437,0.0001337336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.392939,"threshold_uncertainty_score":0.4166927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111099034","doi":"10.3324/haematol.2010.026682","title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Health Resources and Services Administration; U.S. Department of Health and Human Services","keywords":"Medicine; Transplantation; Sibling; Aplastic anemia; Internal medicine; Proportional hazards model; Pediatrics; Surgery; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.03377049944666958,"gpt":0.3244301283212007,"spread":0.2906596288745311,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002366225,0.000277001,0.0007921362,0.0002566208,0.00006512734,0.00001851453,0.00008520905,0.0002789022,0.0002770032],"category_scores_gemma":[0.0001528769,0.0001985332,0.0003256145,0.0001971284,0.0001035937,0.00008457699,0.000006529316,0.0001562005,0.00001792574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004008298,"about_ca_system_score_gemma":0.00008041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004610606,"about_ca_topic_score_gemma":0.0000408751,"domain_scores_codex":[0.9984013,0.00004257936,0.0005931615,0.0003354766,0.0002754154,0.0003520077],"domain_scores_gemma":[0.9986128,0.0006246472,0.0002164667,0.0003033241,0.0001000758,0.0001426821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005047178,0.0004282696,0.3091053,0.003197913,0.000181369,0.00108411,0.00195072,0.0002016789,0.6780877,0.0003804911,0.00003988172,0.0002954163],"study_design_scores_gemma":[0.00934488,0.001457697,0.8196504,0.001249289,0.001419054,0.003044284,0.0002536366,0.00276265,0.1594041,0.000687003,0.00001530975,0.0007117648],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911138,0.00002087229,0.007135979,0.0001016542,0.0002201549,0.0009604158,0.00007998153,0.00009091217,0.0002762213],"genre_scores_gemma":[0.9846754,0.00002081481,0.01490917,0.00008212843,0.00003565233,0.00008214358,0.0001162906,0.00003666477,0.00004170639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5186836,"threshold_uncertainty_score":0.8095949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128816533","doi":"10.3324/haematol.2009.017178","title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; Cancer Research UK","keywords":"Mesenchymal stem cell; Myeloid leukemia; Cancer research; Imatinib; Stromal cell; Bone marrow; Progenitor cell; Leukemia; Imatinib mesylate; Stem cell; Immunology; Biology; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01425844564813957,"gpt":0.2467644451454297,"spread":0.2325059994972901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005348166,0.0009398994,0.00153901,0.0001887664,0.0005772763,0.0001147186,0.0007544493,0.0008278012,0.002587195],"category_scores_gemma":[0.0002093457,0.0006188556,0.0005315741,0.0005487046,0.0004321457,0.0002166288,0.0003422409,0.002113593,0.002024055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001787748,"about_ca_system_score_gemma":0.001522386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00153961,"about_ca_topic_score_gemma":0.0004283439,"domain_scores_codex":[0.9949725,0.0002673748,0.001009967,0.001376732,0.0009524041,0.001421066],"domain_scores_gemma":[0.9963851,0.0005906736,0.0006140639,0.001765297,0.0001665483,0.0004783396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004239082,0.0003251096,0.001276572,0.0001629332,0.0004223399,0.0003405571,0.0005130567,0.000006622472,0.9863181,0.00004770686,0.002650416,0.007512689],"study_design_scores_gemma":[0.005310959,0.001372249,0.01487336,0.0001788761,0.0004532772,0.0006589424,0.0001280377,0.00216491,0.9722584,0.0002497108,0.001668449,0.0006827972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899568,0.0002617319,0.0003084104,0.0009106673,0.0008836378,0.003667579,0.00007555393,0.000388889,0.003546716],"genre_scores_gemma":[0.989628,0.00007127603,0.007484875,0.0003168872,0.0006240855,0.0008882241,0.0001013681,0.0001256144,0.0007596915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01405966,"threshold_uncertainty_score":0.9996263,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3004873674","doi":"10.3324/haematol.2019.220962","title":"Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Bortezomib; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Myeloid leukemia; Oncology; Induction chemotherapy; Multiple myeloma; Leukemia; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.02054202687182094,"gpt":0.2999462043802187,"spread":0.2794041775083978,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002881373,0.0006547059,0.001728574,0.00005866294,0.000319518,0.00007520334,0.0004815269,0.0003404483,0.0001778859],"category_scores_gemma":[0.000193332,0.000257149,0.0003047026,0.0002538718,0.0004847285,0.0001070053,0.0001190987,0.0005699922,0.00002730468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001649389,"about_ca_system_score_gemma":0.001532782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009522591,"about_ca_topic_score_gemma":0.000305354,"domain_scores_codex":[0.9965245,0.0001178458,0.0006530553,0.001218527,0.0006642603,0.0008218487],"domain_scores_gemma":[0.997291,0.0005325047,0.0004549721,0.001078018,0.0002067107,0.0004368245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05492407,0.0007763179,0.8624781,0.00007251358,0.0160077,0.008219437,0.004841451,0.000008693867,0.00661853,0.0004244471,0.01402792,0.03160085],"study_design_scores_gemma":[0.07259815,0.04658398,0.7633582,0.0001630868,0.004042692,0.01503273,0.001614739,0.0002754772,0.06206899,0.0002817426,0.03236258,0.001617681],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9414054,0.0001175051,0.002911237,0.04845302,0.00005793258,0.005480774,0.0009455896,0.0003228991,0.0003056021],"genre_scores_gemma":[0.9555148,0.0004298998,0.02710429,0.0132342,0.0004546249,0.001513101,0.001002669,0.0001489021,0.0005975536],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09911992,"threshold_uncertainty_score":0.9999881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125523937","doi":"10.3324/haematol.2011.056531","title":"A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quest University Canada; University of Alberta","funders":"","keywords":"International Prognostic Index; Medicine; Epoch (astronomy); Rituximab; Vincristine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Etoposide; Cancer; Germinal center; Single Center; Prednisone; Oncology; Cyclophosphamide; B cell; Chemotherapy; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.03265571834827629,"gpt":0.280381009607812,"spread":0.2477252912595357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008655569,0.0002399744,0.001208056,0.0002564801,0.00002573375,0.000005751716,0.00008676606,0.0001013927,0.0000568033],"category_scores_gemma":[0.00001758295,0.000148552,0.000106175,0.0005782241,0.00008226948,0.00003605361,0.00006531015,0.00004612184,0.000002340474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001228419,"about_ca_system_score_gemma":0.00003304482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006135767,"about_ca_topic_score_gemma":0.002711808,"domain_scores_codex":[0.9985706,0.00007489574,0.000491984,0.0003937249,0.0002106364,0.000258122],"domain_scores_gemma":[0.9991513,0.00004216972,0.0002523776,0.0003801491,0.00007409037,0.0000999332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006384345,0.07045875,0.9246247,0.00008906149,0.001337744,0.00107359,0.001290034,6.831426e-7,0.000235851,0.00006154179,0.00001775234,0.0001718293],"study_design_scores_gemma":[0.08640742,0.001380196,0.9037953,0.00007157199,0.002709266,0.00002899715,0.0007642016,0.0002909069,0.004380634,0.000002911295,0.00001192432,0.0001566979],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981018,0.0009452522,0.00002143727,0.00001891639,0.00001105867,0.000634597,0.00007055458,0.0000223341,0.0001740859],"genre_scores_gemma":[0.999238,0.0001216066,0.0003260739,0.00008540571,0.000001100679,0.0001339749,0.00004913867,0.00001597434,0.00002869248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08576898,"threshold_uncertainty_score":0.9275485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241096387","doi":"10.3324/haematol.2013.092155","title":"Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Hazard ratio; Placebo; Internal medicine; Randomized controlled trial; Confidence interval; Janus kinase 2; Myeloproliferative neoplasm; Anemia; Surgery; Gastroenterology; Bone marrow; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01293538303997603,"gpt":0.2314839646634885,"spread":0.2185485816235125,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001384003,0.0002176072,0.0009064147,0.0001030886,0.00003601157,0.000007613349,0.00006599456,0.0001007236,0.0001096108],"category_scores_gemma":[0.0001433555,0.0001202392,0.00004733213,0.0002090836,0.0002320722,0.00006210508,0.00004224465,0.0001091684,0.00000958961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002421856,"about_ca_system_score_gemma":0.00005986993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003293395,"about_ca_topic_score_gemma":0.0003023757,"domain_scores_codex":[0.99844,0.00008031667,0.0005347045,0.0003234472,0.0003604045,0.0002611691],"domain_scores_gemma":[0.998772,0.0003075204,0.000262137,0.0002941896,0.0002138135,0.0001503993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009075544,0.0008751877,0.987075,0.0001362014,0.0001602725,0.00003290218,0.0005370748,0.000001858877,0.00001172262,0.0008173445,0.0001380353,0.00113887],"study_design_scores_gemma":[0.02726137,0.003688028,0.9662166,0.0006348534,0.00009803639,0.00001734801,0.0003001977,0.00000937794,0.001508517,0.00003289966,0.0001043741,0.0001283577],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948586,0.00004500619,0.000006080428,0.0004322446,0.00002530351,0.001254223,0.00007461903,0.0000198318,0.003284066],"genre_scores_gemma":[0.9977701,0.00008117505,0.001840202,0.00003932891,0.000007167125,0.00008072748,0.0001033067,0.00001583012,0.00006219994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02085835,"threshold_uncertainty_score":0.4903213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111606093","doi":"10.3324/haematol.2013.085175","title":"Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Hospital for Sick Children; Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund","keywords":"CDKN2A; Cytogenetics; Leukemia; Biology; Multiplex ligation-dependent probe amplification; Acute lymphocytic leukemia; Copy-number variation; CDKN2B; Karyotype; Chromosomal translocation; Immunophenotyping; Cancer research; Oncology; Immunology; Genetics; Gene; Chromosome; Medicine; Lymphoblastic Leukemia; Flow cytometry","retraction":null,"screen_n_in":null,"score":{"opus":0.0129978582267942,"gpt":0.2749340297644282,"spread":0.261936171537634,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003632722,0.0003191531,0.0008520582,0.0001674996,0.0001023575,0.00007438741,0.0002125489,0.0005913827,0.00009491105],"category_scores_gemma":[0.0005762543,0.0002166633,0.00009389963,0.0003771774,0.0002192356,0.0001008308,0.0001796312,0.0005800245,0.000189662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008548432,"about_ca_system_score_gemma":0.000731024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001735187,"about_ca_topic_score_gemma":0.0001127177,"domain_scores_codex":[0.9973255,0.0002501629,0.000602724,0.0005719271,0.0005807055,0.0006689407],"domain_scores_gemma":[0.9976888,0.001067796,0.0002591306,0.0004047921,0.0002512317,0.0003282614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006374542,0.0008416868,0.9759591,0.0001672865,0.0004625578,0.0009294215,0.0002716711,0.0000231989,0.0009844231,0.00008513208,0.01323423,0.006403841],"study_design_scores_gemma":[0.01125841,0.001989837,0.9770992,0.0002003296,0.0004078004,0.001972314,0.0001776996,0.002162772,0.00370104,0.0001767419,0.0004713692,0.0003824692],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946294,0.0007784331,0.0001529777,0.001233998,0.00006361554,0.001219626,0.00001401996,0.0001115721,0.001796355],"genre_scores_gemma":[0.9915265,0.001047217,0.005599184,0.0007594465,0.00007992747,0.0001270468,0.00004208467,0.00004384809,0.0007747026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01276286,"threshold_uncertainty_score":0.8835273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2418937816","doi":"10.3324/haematol.2016.143677","title":"Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Open label; Snapshot (computer storage); Oncology; Internal medicine; Clinical trial; Phases of clinical research; Bone marrow; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.08403487765658953,"gpt":0.3716524044608081,"spread":0.2876175268042186,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003926274,0.00027253,0.00103926,0.0002034355,0.00004300961,0.00003215782,0.000312967,0.00008812783,0.00007494278],"category_scores_gemma":[0.0003461734,0.0001287905,0.00002719237,0.0003311593,0.0001459756,0.0002592885,0.0001755858,0.0001154697,0.000001005235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007153014,"about_ca_system_score_gemma":0.00005025481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001967677,"about_ca_topic_score_gemma":0.000713922,"domain_scores_codex":[0.9973664,0.0005036462,0.0009411215,0.0004952954,0.0003868702,0.0003066383],"domain_scores_gemma":[0.9984583,0.0005122329,0.000376995,0.0004150719,0.0001449966,0.00009246709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09324611,0.1128724,0.7870324,0.00004832068,0.00004505996,0.00004963908,0.002008785,3.032122e-7,0.00003624918,0.00004379294,0.000009091007,0.004607868],"study_design_scores_gemma":[0.3047995,0.02996984,0.663419,0.0005923272,0.00005312312,0.000001560672,0.0003771636,0.00000414376,0.0006588114,0.00001102723,0.000007205577,0.0001062695],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929414,0.00003418275,0.000001720716,0.0001302136,0.00004778181,0.006610507,0.00006393025,0.000007220418,0.0001630818],"genre_scores_gemma":[0.9992145,0.0000374154,0.0001414197,0.00008500392,0.00000801836,0.0004274425,0.0000689041,0.00001486269,0.000002480944],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2115534,"threshold_uncertainty_score":0.5251924,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2917196540","doi":"10.3324/haematol.2019.216796","title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; Baxalta; National Science Foundation; National Institutes of Health; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"ADAMTS13; Compound heterozygosity; Medicine; Thrombotic thrombocytopenic purpura; Gastroenterology; Internal medicine; Disease; Genotype; Allele; Age of onset; Pediatrics; Genetics; Biology; Gene; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.02209910791240419,"gpt":0.2572903582035729,"spread":0.2351912502911687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003340553,0.0002539291,0.0004438966,0.00004800734,0.0005285309,0.00007338753,0.001244442,0.0001738685,0.01042981],"category_scores_gemma":[0.000147178,0.0001636717,0.0001832316,0.0000780989,0.0002684951,0.0001052164,0.000780104,0.0002119838,0.01188384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001744974,"about_ca_system_score_gemma":0.00006167026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004335115,"about_ca_topic_score_gemma":0.00006365433,"domain_scores_codex":[0.9982378,0.000176966,0.0004633853,0.0004919199,0.0001353945,0.0004945372],"domain_scores_gemma":[0.9983602,0.0004468063,0.0002431984,0.0008459365,0.00007086316,0.00003301838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004479685,0.0002412284,0.1205025,0.0000780034,0.000897891,0.0001437692,0.0003085483,0.00001184407,0.03756012,0.01943266,0.8201365,0.0002389048],"study_design_scores_gemma":[0.003348887,0.0004031202,0.1634139,0.0002374882,0.0001385058,0.002489954,0.001536193,0.00002698813,0.01587547,0.002055427,0.8097452,0.000728938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694229,0.00301827,0.000006234674,0.00332926,0.003900622,0.0007722905,0.00006820291,0.0001451801,0.01933708],"genre_scores_gemma":[0.9841399,0.0001372066,0.00002761284,0.0003056822,0.00004155656,0.00009543904,0.0002034245,0.00001597798,0.01503322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04291132,"threshold_uncertainty_score":0.9904748,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2154610817","doi":"10.3324/haematol.2011.049676","title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Etablissement Français du Sang; GIS-Institut des Maladies Rares","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Medicine; Purpura (gastropod); Thrombocytopenic purpura; Internal medicine; Immunology; Pediatrics; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.08371613946296001,"gpt":0.2979102285476568,"spread":0.2141940890846968,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005226068,0.0001987941,0.0004652143,0.00006254471,0.0002367548,0.00001267361,0.000317189,0.0001675948,0.0000683278],"category_scores_gemma":[0.0002689318,0.0001335671,0.00004942327,0.0001288617,0.0001821717,0.0001817707,0.0002055522,0.00009094751,0.00001307355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000098524,"about_ca_system_score_gemma":0.0001032053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003753443,"about_ca_topic_score_gemma":0.00007971562,"domain_scores_codex":[0.9983245,0.0002767027,0.0005486386,0.0003064432,0.00008191089,0.0004617776],"domain_scores_gemma":[0.9991003,0.0002095905,0.0003067908,0.0002590629,0.00009711443,0.00002711252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004321751,0.002108568,0.9002657,0.0004354739,0.0002887994,0.000004685037,0.05898143,0.000332017,0.02532609,0.01044243,0.0007771954,0.0006054246],"study_design_scores_gemma":[0.002993295,0.0002991657,0.9570342,0.0006016853,0.000122205,0.0001622889,0.00549436,0.001684875,0.02986648,0.001057767,0.0001567801,0.000526847],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947265,0.002000995,0.001703436,0.00004301864,0.0001263822,0.001047053,0.00007827818,0.00004050276,0.0002338207],"genre_scores_gemma":[0.9989474,0.00002398137,0.0003460989,0.00003426486,0.000003394487,0.0005010965,0.00008454432,0.000008856001,0.00005040121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05676854,"threshold_uncertainty_score":0.5446708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989402731","doi":"10.3324/haematol.11203","title":"Pediatric acute myeloid leukemia: towards high-quality cure of all patients","year":2007,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Myeloid leukemia; Pharmacogenomics; Minimal residual disease; Oncology; Disease; Internal medicine; Leukemia; Intensive care medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.1125435943222047,"gpt":0.4181493666006389,"spread":0.3056057722784342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001449651,0.001057458,0.006824554,0.0008976778,0.000102005,0.0000269752,0.001050001,0.002226565,0.0005924144],"category_scores_gemma":[0.0009990656,0.0007109329,0.001417349,0.001498107,0.0003313442,0.00009829355,0.0007655521,0.002457254,0.0007122534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001620417,"about_ca_system_score_gemma":0.00284071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001739431,"about_ca_topic_score_gemma":0.000004290625,"domain_scores_codex":[0.9927104,0.0005902381,0.002572817,0.001217455,0.001667441,0.001241657],"domain_scores_gemma":[0.9948043,0.0007184472,0.001565104,0.001626626,0.0007008262,0.0005847335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002975085,0.000722922,0.001095697,0.09601409,0.001734281,0.002302561,0.00009106655,1.238106e-7,0.000001310539,0.001207538,0.04150867,0.8550242],"study_design_scores_gemma":[0.001913229,0.0007233819,0.00174696,0.00296988,0.00505116,0.0007061191,0.00001402528,8.215052e-7,0.00002504491,0.0001009936,0.9859799,0.0007685518],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004708206,0.9858673,0.00005193868,0.000108609,0.000416178,0.003060109,0.0004515781,0.0002337531,0.005102345],"genre_scores_gemma":[0.0004315724,0.9936695,0.002365574,0.0002743761,0.0004152455,0.0001815942,0.001567387,0.0001424745,0.000952271],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9444712,"threshold_uncertainty_score":0.9998441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015129246","doi":"10.3324/haematol.2020.246603","title":"Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hemolysis; Oxidative stress; Red blood cell; Glutathione; Antioxidant; Biology; Internal medicine; Immunology; Biochemistry; Medicine; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.04113521748334037,"gpt":0.274631982799414,"spread":0.2334967653160736,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002260091,0.0003644034,0.00110078,0.00004999612,0.0001221991,0.00002232278,0.00008326409,0.0002955803,0.0002093199],"category_scores_gemma":[0.0001740039,0.0002708851,0.0001231156,0.0002539896,0.0001616126,0.0001579777,0.0001257103,0.0004033569,0.00001222515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002111932,"about_ca_system_score_gemma":0.00005234154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001333783,"about_ca_topic_score_gemma":0.00002324937,"domain_scores_codex":[0.9980099,0.0003105151,0.0003675782,0.000692069,0.0001739371,0.000445999],"domain_scores_gemma":[0.9990079,0.0001463156,0.0001900036,0.0002736442,0.00003482632,0.0003472481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001527375,0.0005084418,0.0009836531,0.0002139018,0.0001130069,0.002056832,0.001271937,0.000004178159,0.9917664,0.0001938221,0.0009802534,0.0003801993],"study_design_scores_gemma":[0.008205402,0.001581891,0.02989455,0.00006451039,0.0002892805,0.000547174,0.0003672743,0.0005818654,0.9552491,0.0009867928,0.00173066,0.0005014825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943882,0.002530206,0.0007736782,0.00114294,0.00009168747,0.0006412863,0.00009633444,0.0001416902,0.0001940095],"genre_scores_gemma":[0.994785,0.001360977,0.001600327,0.002029823,0.0000437683,0.00004463352,0.00003636897,0.00002719673,0.00007187941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03651728,"threshold_uncertainty_score":0.9999743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2988993561","doi":"10.3324/haematol.2019.225086","title":"Novel evidence for a greater burden of ambient air pollution on cardiovascular disease","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Air pollution; Environmental health; Life expectancy; Particulates; Cardiovascular health; Disease; Coronary artery disease; Diabetes mellitus; Air pollutants; Particulate pollution; Heart failure; Adverse effect; Burden of disease; Disease burden; Intensive care medicine; Cardiology; Internal medicine; Population; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.3037284581445227,"gpt":0.3940074319692123,"spread":0.09027897382468969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000787675,0.0003479198,0.00177839,0.00005983263,0.0001113258,0.00001022905,0.0004144347,0.0002752857,0.0002351645],"category_scores_gemma":[0.0004876018,0.000233988,0.001141563,0.0001885173,0.0001742052,0.00009974856,0.0001915726,0.0001798369,0.0007706505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002832931,"about_ca_system_score_gemma":0.0001022035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002574399,"about_ca_topic_score_gemma":0.000002115793,"domain_scores_codex":[0.997548,0.0002114899,0.0006221446,0.0006540095,0.0005229697,0.000441372],"domain_scores_gemma":[0.9981274,0.0002692128,0.0003977227,0.000938678,0.00001343268,0.0002535555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003148365,0.0003183331,0.00004583639,0.1002746,0.0005293072,0.00005145903,0.0003652336,0.004294832,0.000001226632,0.001371509,0.01198837,0.8804444],"study_design_scores_gemma":[0.0001922429,0.000242534,0.000334659,0.01121061,0.0009556276,0.00003282882,0.000008737952,0.00007506862,0.000002303584,0.00007665314,0.9865707,0.0002979937],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009896272,0.993765,0.001793681,0.000686338,0.0001947159,0.002970636,0.0001864365,0.00004272406,0.0002614957],"genre_scores_gemma":[0.002033094,0.9956477,0.0008652688,0.0006838653,0.00006712645,0.0003327969,0.00003256181,0.00002890514,0.0003086296],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9745824,"threshold_uncertainty_score":0.990541,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2970999010","doi":"10.3324/haematol.2019.223073","title":"Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"review","venue":"Haematologica","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"Astellas Pharma; Gilead Sciences; Pfizer","keywords":"Medicine; Hematopoietic stem cell transplantation; Human herpesvirus 6; Disease; Transplantation; Encephalitis; Hematologic disease; Stem cell; Immunology; Population; Hematopoietic stem cell; Intensive care medicine; Human immunodeficiency virus (HIV); Haematopoiesis; Internal medicine; Viral disease; Herpesviridae; Biology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.1233474621870506,"gpt":0.3560840690528848,"spread":0.2327366068658342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003551384,0.000323692,0.001316338,0.0002311213,0.00005091172,0.00003109653,0.0001246676,0.0001847065,0.0000336755],"category_scores_gemma":[0.00001531669,0.0001756897,0.0001438196,0.0002610677,0.0001001513,0.00005285882,0.00005718358,0.0003074048,0.00003560401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000683453,"about_ca_system_score_gemma":0.00007161444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000965348,"about_ca_topic_score_gemma":0.0002304876,"domain_scores_codex":[0.9980636,0.000228552,0.0007586758,0.0004499035,0.0002466727,0.0002526267],"domain_scores_gemma":[0.9988483,0.0002819162,0.0003152954,0.0003747586,0.0001352985,0.00004449381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003718845,0.002929037,0.4148307,0.2982726,0.0007396517,0.001183762,0.001709824,0.00003063436,0.000002773179,0.004679475,0.001645274,0.2702575],"study_design_scores_gemma":[0.01752752,0.005196927,0.4901005,0.2639991,0.004566303,0.0005989926,0.0005217271,0.00008701868,0.00006309103,0.0006651698,0.2145755,0.002098182],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4429279,0.5447697,0.000197918,0.0001597429,0.000127248,0.008328371,0.0003154853,0.0000547624,0.003118846],"genre_scores_gemma":[0.1221102,0.8768533,0.0001693554,0.00005449337,0.00001137556,0.0004734656,0.0001570952,0.00003036781,0.0001402499],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3320837,"threshold_uncertainty_score":0.7164416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159601358","doi":"10.3324/haematol.2011.043422","title":"Familial myelodysplastic syndromes: a review of the literature","year":2011,"lang":"en","type":"review","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Myelodysplastic syndromes; Platelet disorder; Medicine; RUNX1; Myeloid leukemia; Transplantation; Hematopoietic stem cell transplantation; Leukemia; Immunology; Disease; Internal medicine; Stem cell; Genetics; Haematopoiesis; Biology; Bone marrow; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.08086625824052283,"gpt":0.3586391539865774,"spread":0.2777728957460545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005216133,0.0006039277,0.004676589,0.0002024379,0.00008024748,0.00001334773,0.0009965195,0.0007831916,0.0008378382],"category_scores_gemma":[0.002142004,0.0002690004,0.00152348,0.001386713,0.0003702885,0.00003793311,0.0005191752,0.001704357,0.0004751504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001851106,"about_ca_system_score_gemma":0.001277236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006107182,"about_ca_topic_score_gemma":6.238941e-7,"domain_scores_codex":[0.9966468,0.0005751859,0.001158337,0.0005959788,0.0005277614,0.0004959875],"domain_scores_gemma":[0.9967729,0.0004383469,0.0006929423,0.001626973,0.0002862742,0.0001825643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001998815,0.00008752203,0.000003983504,0.7752614,0.0003251742,0.0008274073,0.0000481194,1.458528e-9,2.05312e-7,0.0009391913,0.02818226,0.1943048],"study_design_scores_gemma":[0.0001257746,0.0001021781,0.000007204279,0.4107637,0.00131059,0.009059554,0.000003024056,1.853341e-7,7.736185e-7,0.00003127308,0.5784562,0.0001395869],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000005419393,0.9890464,0.000003084084,0.0001694949,0.0002678575,0.0029081,0.00009879671,0.00006525665,0.007435621],"genre_scores_gemma":[0.000006812604,0.9962464,0.0002790237,0.0005052479,0.00009601492,0.0003114536,0.0001189216,0.00006519548,0.002370905],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.550274,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121399230","doi":"10.3324/haematol.11644","title":"Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Thalidomide; Dexamethasone; Internal medicine; Vincristine; Complete response; Adverse effect; Melphalan; Multiple myeloma; Randomized controlled trial; Gastroenterology; Chemotherapy; Induction chemotherapy; Urology; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.02943358729859761,"gpt":0.3032299416468039,"spread":0.2737963543482063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001173839,0.0002986721,0.0005377147,0.0002652025,0.0001011524,0.00003342924,0.00007899139,0.000181185,0.00008514963],"category_scores_gemma":[0.0006596617,0.0001593678,0.00008024702,0.0003693127,0.0001945095,0.0001068008,0.00005168446,0.0002046449,0.0000293343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002598927,"about_ca_system_score_gemma":0.0001077733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003049426,"about_ca_topic_score_gemma":0.006714441,"domain_scores_codex":[0.9974676,0.0008338675,0.0004246318,0.0004423264,0.0002191002,0.000612445],"domain_scores_gemma":[0.9982439,0.001031698,0.0000906117,0.0003857783,0.00004588358,0.0002021042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08341423,0.001193854,0.8770288,0.00002053573,0.0001185423,0.006321743,0.0008874683,0.000002337684,0.00132524,0.00002941358,0.00001157215,0.02964627],"study_design_scores_gemma":[0.01492481,0.002527971,0.9712399,0.0001134457,0.00003257968,0.0004497281,0.0002944146,0.00008375784,0.009857447,0.00009408624,0.0002539661,0.0001278966],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960208,0.0009228337,0.000003018692,0.0009438339,0.00003918426,0.001943605,0.0000164853,0.00006026644,0.00004997277],"genre_scores_gemma":[0.9983387,0.0006088511,0.0001442729,0.0001486349,0.00004607038,0.0005023588,0.00005121963,0.00002250389,0.0001374038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09421109,"threshold_uncertainty_score":0.6498832,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158196950","doi":"10.3324/haematol.13151","title":"Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia","year":2008,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphocytosis; Dasatinib; Natural killer cell; Lymphocyte; Immunology; CD16; CD3; Biology; Medicine; Cytotoxicity; Myeloid leukemia; CD8; Imatinib; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.03405269464848501,"gpt":0.2943099288139732,"spread":0.2602572341654882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004655925,0.0007698711,0.001592308,0.000262602,0.0007365209,0.00005596629,0.0005343187,0.0005921387,0.0006261076],"category_scores_gemma":[0.0007681739,0.0004646255,0.0004686764,0.0008973517,0.0006934403,0.000232421,0.000181667,0.0007945881,0.00009790689],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.009295838,"about_ca_system_score_gemma":0.006583428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001340699,"about_ca_topic_score_gemma":0.00005703458,"domain_scores_codex":[0.9950731,0.0002367295,0.0007829298,0.00112472,0.001168439,0.001614077],"domain_scores_gemma":[0.9965366,0.001218257,0.0003916636,0.0008403934,0.0006015996,0.0004114521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1849427,0.01796211,0.02181081,0.004516006,0.01211153,0.1187384,0.02589686,0.0003265882,0.05232881,0.004270498,0.5543073,0.002788441],"study_design_scores_gemma":[0.5276347,0.01805539,0.05062881,0.002859779,0.001262606,0.03861934,0.001917411,0.08099233,0.223101,0.0002324754,0.04879929,0.005896872],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890337,0.003939864,0.0001296541,0.00134136,0.0006929503,0.003335123,0.00008975458,0.0004802144,0.0009574058],"genre_scores_gemma":[0.9868779,0.001028567,0.001396657,0.002546973,0.0002590913,0.0004409601,0.0008584897,0.0001462524,0.006445088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.505508,"threshold_uncertainty_score":0.9997805,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108880951","doi":"10.3324/haematol.2013.098103","title":"p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"Celgene","keywords":"Myelodysplastic syndromes; Oncology; Internal medicine; Medicine; Outcome (game theory); Protein expression; Biology; Genetics; Gene; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.01351225560887367,"gpt":0.2483177518828838,"spread":0.2348054962740101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000457641,0.0004049349,0.0008937955,0.0003301293,0.0001407156,0.00003969311,0.0003360896,0.00030409,0.0002252178],"category_scores_gemma":[0.0008912978,0.0002284618,0.00006150531,0.0004766995,0.0002437513,0.0001888753,0.0002050123,0.000945444,0.000195184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002244489,"about_ca_system_score_gemma":0.0001759188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005913424,"about_ca_topic_score_gemma":0.00004186903,"domain_scores_codex":[0.9966052,0.0002770206,0.0004811652,0.0007269118,0.001141585,0.0007681687],"domain_scores_gemma":[0.9982049,0.000210975,0.0002711544,0.0007467722,0.0002163545,0.0003498221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003480997,0.0005746469,0.9935296,0.0002760885,0.00005534789,0.0008310881,0.00009773495,0.00005037327,0.00009679623,0.0000897034,0.0002956919,0.0006220018],"study_design_scores_gemma":[0.01277176,0.006157029,0.9762185,0.001310225,0.00009753533,0.0003462218,0.00008404303,0.000837895,0.001189306,0.0000946531,0.0004446038,0.0004482373],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947863,0.00003027642,0.001032548,0.0002541527,0.00004910395,0.002091292,0.00001307943,0.0001844511,0.001558802],"genre_scores_gemma":[0.9953802,0.000005334831,0.003440516,0.000124743,0.00003070513,0.0002878708,0.00003830339,0.00006156338,0.0006307699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01731104,"threshold_uncertainty_score":0.93164,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112843683","doi":"10.3324/haematol.2008.005348","title":"Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review","year":2009,"lang":"en","type":"review","venue":"Haematologica","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton General Hospital; McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Thrombocytopenic purpura; Internal medicine; Helicobacter pylori; Odds ratio; Adverse effect; Immune system; Hematology; Immunology; Gastroenterology; Randomized controlled trial; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.0305027893274073,"gpt":0.3056950531228374,"spread":0.2751922637954301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007602231,0.001325909,0.01049127,0.0005201999,0.0001564804,0.00004920634,0.0002246583,0.0004738182,0.00002681657],"category_scores_gemma":[0.0004222985,0.0006791451,0.0002860611,0.001037279,0.0002174599,0.000121978,0.0001329372,0.000724668,0.0001365225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008919635,"about_ca_system_score_gemma":0.0002999281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004020965,"about_ca_topic_score_gemma":0.00008050009,"domain_scores_codex":[0.9945902,0.001045474,0.001870088,0.001150559,0.0005355325,0.0008081517],"domain_scores_gemma":[0.996891,0.00027449,0.0009969368,0.001223667,0.0003050532,0.000308805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.007995278,0.001768164,0.03614146,0.9226488,0.006608302,0.002377378,0.0004967554,7.475378e-7,1.907762e-7,0.00001817551,0.0003083577,0.0216364],"study_design_scores_gemma":[0.006195184,0.01887079,0.02578383,0.867557,0.01198344,0.005475535,0.00002396266,3.67454e-7,6.869338e-7,0.000001909143,0.06326847,0.000838785],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04406191,0.9383948,0.000006577556,0.0007381135,0.0000874531,0.01641386,0.00003451293,0.0001705091,0.00009220148],"genre_scores_gemma":[0.002447305,0.9929066,0.0002775874,0.0006823412,0.00002531922,0.003244999,0.0001342382,0.00009882894,0.0001828179],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.06296011,"threshold_uncertainty_score":0.9999492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604831554","doi":"10.3324/haematol.2016.160754","title":"Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","year":2017,"lang":"en","type":"article","venue":"Haematologica","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Pontificia Universidad Católica de Chile; Universitair Ziekenhuis Gent; Universidad de Murcia; Universiteit Gent; Queen's University; Ain Shams University; Inselspital, Universitätsspital Bern; Instituto de Salud Carlos III; European Hematology Association; Fondazione Umberto Veronesi; University of Pennsylvania","keywords":"Medicine; Platelet disorder; Platelet; Bleeding diathesis; Bernard–Soulier syndrome; Incidence (geometry); Surgery; Blood Platelet Disorders; Desmopressin; Internal medicine; Pediatrics; Platelet aggregation","retraction":null,"screen_n_in":null,"score":{"opus":0.02620889103871042,"gpt":0.2644127558795973,"spread":0.2382038648408868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009611119,0.000106403,0.0004261085,0.00008268721,0.0001019106,0.0000120564,0.00004218187,0.00007591493,0.00002296526],"category_scores_gemma":[0.0001844374,0.00007169331,0.00003766309,0.00005413984,0.00005978383,0.0001116636,0.00003250586,0.0000804056,0.000003122228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008856061,"about_ca_system_score_gemma":0.0000149062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006513538,"about_ca_topic_score_gemma":0.00007509075,"domain_scores_codex":[0.9993492,0.00002477327,0.0001857966,0.0001743153,0.0001151932,0.0001507435],"domain_scores_gemma":[0.9994524,0.00005520089,0.0002505947,0.0001639783,0.0000335367,0.00004428799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004154298,0.0003924818,0.9927392,0.00007972433,0.00007746539,0.00008480867,0.00005236898,6.466444e-7,0.000006493915,0.00003124611,0.00002326915,0.006096841],"study_design_scores_gemma":[0.002864054,0.0002580515,0.9958903,0.0002386571,0.00005322612,0.00001709929,0.00003022269,0.00005411388,0.0001574571,0.0003343642,0.00002705673,0.00007540117],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986706,0.0002010855,0.000003734502,0.000097476,0.00002517863,0.0003504495,0.000008369941,0.00001553533,0.000627531],"genre_scores_gemma":[0.9993866,0.0004101103,0.0001142486,0.000009364479,0.000002286663,0.00001440445,0.00002473062,0.000008150173,0.00003009227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00602144,"threshold_uncertainty_score":0.2923568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205969691","doi":"10.3324/haematol.2021.279012","title":"First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab &lt;i&gt;versus&lt;/i&gt; chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial","year":2022,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Cilag; Juno Therapeutics; Kite Pharma; Cancer Research UK; Genentech; Horizon Therapeutics; Pfizer; Moderna; Incyte; Pharmacyclics; Agios Pharmaceuticals; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Clovis Oncology; Teva Pharmaceutical Industries; AstraZeneca; Barts Charity; Exelixis; Karyopharm Therapeutics; Unum Therapeutics; Daiichi Sankyo Europe; Calithera Biosciences; Gilead Sciences; MorphoSys; Celgene; TG Therapeutics; Amgen; GlaxoSmithKline","keywords":"Obinutuzumab; Ibrutinib; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Internal medicine; Oncology; Hazard ratio; Leukemia; Chemotherapy; Confidence interval; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.04504888166279691,"gpt":0.308024079257522,"spread":0.2629751975947251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001477069,0.0008783814,0.005260473,0.0008024637,0.0006956901,0.00004038031,0.001053033,0.0003286028,0.002888191],"category_scores_gemma":[0.0007893121,0.0005305194,0.002080514,0.003497701,0.002178782,0.0001136046,0.0006725813,0.0004292452,0.00002545471],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.3317148,"about_ca_system_score_gemma":0.1157102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002535283,"about_ca_topic_score_gemma":0.001063965,"domain_scores_codex":[0.9919623,0.000902639,0.002149523,0.001267627,0.002451783,0.001266182],"domain_scores_gemma":[0.9929442,0.002368267,0.00152221,0.002360838,0.0004223564,0.0003820999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8176984,0.0004514612,0.000002029641,0.0003904195,0.007246044,0.001324621,0.001797733,0.167874,0.0003290661,0.001585047,0.0005938042,0.0007074323],"study_design_scores_gemma":[0.5896574,0.008300942,0.000004270477,0.0001057862,0.006997587,0.0005648253,0.0002163651,0.3880878,0.001565447,0.00003018532,0.004134812,0.000334586],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855472,0.00443143,0.0002518965,0.0001836294,0.0005522518,0.006088244,0.0002380752,0.0001560368,0.002551278],"genre_scores_gemma":[0.992657,0.001156229,0.0001838173,0.00006653169,0.0001780881,0.001735364,0.000294525,0.00008321652,0.003645216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2280409,"threshold_uncertainty_score":0.9997146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2066523152","doi":"10.3324/haematol.2010.037408","title":"High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy","year":2011,"lang":"en","type":"article","venue":"Haematologica","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Rituximab; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Microvessel; Oncology; Pathology; Cohort; Proportional hazards model; Angiogenesis","retraction":null,"screen_n_in":null,"score":{"opus":0.01153610541487813,"gpt":0.2126957076614251,"spread":0.201159602246547,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005409043,0.0002756883,0.0004279338,0.00004721524,0.00006815931,0.00001407396,0.0001958573,0.0001887851,0.00003949421],"category_scores_gemma":[0.000007466648,0.0001744083,0.0000743538,0.0001149178,0.0000922126,0.000006178516,0.00006341247,0.00004066405,0.00001226225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002639734,"about_ca_system_score_gemma":0.00003842713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001340813,"about_ca_topic_score_gemma":0.0001959538,"domain_scores_codex":[0.9987968,0.00004090897,0.0002338067,0.0004550751,0.0001105063,0.000362874],"domain_scores_gemma":[0.9993346,0.00000711291,0.0001428353,0.0003500528,0.00009133433,0.00007409968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002291105,0.003315032,0.9902736,0.00003499233,0.00005617084,0.00006175187,0.00006975224,3.349279e-7,0.003288837,0.00002233394,0.0001793912,0.0004067269],"study_design_scores_gemma":[0.03022286,0.001104834,0.7747785,0.00002949142,0.00004653425,0.00003920113,0.00004864979,0.000009645262,0.192444,0.000009143576,0.0007819515,0.0004851299],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989582,0.0001733994,0.0002386277,0.00001971881,0.00002680838,0.0002984157,0.00002830421,0.00002825693,0.0002283165],"genre_scores_gemma":[0.9971092,0.00004355797,0.001819632,0.0005445783,0.00001999425,0.00004833045,0.00007874345,0.00003480465,0.0003012064],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.215495,"threshold_uncertainty_score":0.7112166,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110734772","doi":"10.3324/haematol.2010.029389","title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"Bundesministerium für Bildung und Forschung; European Commission","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; CD8; Cytotoxic T cell; Natural killer cell; Degranulation; Biology; Medicine; Disease; Immune system; Pathology; Internal medicine; Genetics; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.01098137334185702,"gpt":0.2641260837821603,"spread":0.2531447104403033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001353368,0.0001880834,0.0005417048,0.00020389,0.0001664751,0.00003387115,0.0001369929,0.0001304473,0.0002073115],"category_scores_gemma":[0.0004229705,0.0001350561,0.00005484543,0.0003989118,0.0003485834,0.0001101254,0.0001156214,0.0003169918,0.000093528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008267569,"about_ca_system_score_gemma":0.0004218183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008128898,"about_ca_topic_score_gemma":0.00005358352,"domain_scores_codex":[0.998515,0.00005042561,0.000337564,0.0003779111,0.0003357078,0.0003834043],"domain_scores_gemma":[0.9991513,0.000140734,0.00005612678,0.0003659814,0.00009785071,0.0001879514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009417154,0.003331682,0.8667996,0.001281416,0.0001689503,0.007540876,0.002280544,0.00008112892,0.04602564,0.01503462,0.001863912,0.04617446],"study_design_scores_gemma":[0.002328797,0.0005337896,0.9931197,0.00009302196,0.00004928427,0.0009590996,0.00047973,0.0002754474,0.0004925118,0.0002935299,0.001151666,0.0002233992],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949062,0.000685122,0.0001245717,0.0008178136,0.00005443666,0.0006311059,0.00001441318,0.00008229876,0.002684048],"genre_scores_gemma":[0.9980622,0.00004504823,0.0009416889,0.0005160117,0.0000171593,0.0001327233,0.00003705014,0.00001859969,0.0002295372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1263201,"threshold_uncertainty_score":0.5507428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2154663549","doi":"10.3324/haematol.2011.060657","title":"Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre","funders":"","keywords":"Deep vein; D-dimer; Thrombosis; Medicine; Value (mathematics); Internal medicine; Cardiology; Surgery; Statistics; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.06642581865203963,"gpt":0.336319196925367,"spread":0.2698933782733274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004867015,0.0002836022,0.0009021313,0.000105909,0.0001851394,0.00003457122,0.0002504613,0.0001610761,0.0006659681],"category_scores_gemma":[0.0001652229,0.0001850618,0.0001366536,0.0002540252,0.000212354,0.000172213,0.0002322146,0.0002091393,0.00003017496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001092657,"about_ca_system_score_gemma":0.00005017249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005779041,"about_ca_topic_score_gemma":0.0008678433,"domain_scores_codex":[0.9976694,0.0003187662,0.000561565,0.0003405667,0.0005156923,0.0005939998],"domain_scores_gemma":[0.9987102,0.0001410005,0.0002511374,0.0005999532,0.00009509738,0.0002026392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005798514,0.007589158,0.981414,0.0001784288,0.0002441509,0.00006215578,0.004855699,0.00006149121,0.0004238242,0.003152271,0.001057959,0.0009028852],"study_design_scores_gemma":[0.001410518,0.0001598735,0.9929597,0.0002174364,0.0004212234,0.00004096564,0.001420498,0.0001304069,0.002201599,0.0002074574,0.0005779531,0.0002523705],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957657,0.0002933565,0.00004104549,0.0003943471,0.0002114617,0.0009632544,0.00001306912,0.00005282841,0.002264966],"genre_scores_gemma":[0.9970344,0.0001694856,0.0008754154,0.001652062,0.00007141643,0.00007985529,0.00005006716,0.00003771671,0.00002959927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01154571,"threshold_uncertainty_score":0.8736219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003181078","doi":"10.3324/haematol.2014.104109","title":"Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Cyclophosphamide; Dexamethasone; Internal medicine; AL amyloidosis; Regimen; Cohort; Amyloidosis; Surgery; Chemotherapy; Multiple myeloma; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.007995014435383987,"gpt":0.24747480473891,"spread":0.2394797903035261,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002159888,0.0004341879,0.000950927,0.00009180792,0.00009268042,0.00001858323,0.000189659,0.0002666726,0.00004827302],"category_scores_gemma":[0.000425231,0.0003109763,0.0001823448,0.0001709386,0.0002829753,0.00001024053,0.0001377996,0.0001179779,0.00001543652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004947733,"about_ca_system_score_gemma":0.00004724089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006705015,"about_ca_topic_score_gemma":0.0001571712,"domain_scores_codex":[0.9977311,0.0003138221,0.0005318872,0.0007809428,0.0001989619,0.0004432328],"domain_scores_gemma":[0.9981837,0.0004691819,0.0004576948,0.0006550572,0.00008146141,0.0001529015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008482203,0.000836202,0.9922681,0.00001994928,0.0003962017,0.00001123341,0.000116412,0.00002220242,0.0005294955,0.00006105089,0.0002356545,0.004655207],"study_design_scores_gemma":[0.008921955,0.002903521,0.949133,0.00004133134,0.0002478351,0.000002692247,0.0001465854,0.000005564473,0.03542349,0.00002540471,0.002763779,0.0003848011],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975158,0.0009769788,0.00005496366,0.00009823017,0.00009109707,0.0007971585,0.0001586013,0.00002971939,0.000277469],"genre_scores_gemma":[0.9943616,0.002908935,0.001911597,0.0001781483,0.00002436352,0.0001889912,0.0002234289,0.00004124032,0.000161721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04313513,"threshold_uncertainty_score":0.9999343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125502424","doi":"10.3324/haematol.2012.083063","title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries","year":2013,"lang":"en","type":"letter","venue":"Haematologica","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Merck Sharp and Dohme; Robert Koch Institut; Masarykova Univerzita; Universität zu Köln; Julius-Maximilians-Universität Würzburg; Celgene; Universität des Saarlandes; Astellas Pharma; Universitätsklinikum Köln; Bundesministerium für Bildung und Forschung; Pfizer Pharmaceuticals; McGill University; Deutsches Zentrum für Infektionsforschung; BioCryst; Central European Institute of Technology; Gilead Sciences; Pfizer; Viropharma; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","keywords":"Mucormycosis; Antifungal; Amphotericin B; Medicine; Internal medicine; Hematologic Neoplasms; Hematopoietic stem cell transplantation; Leukemia; Intensive care medicine; Transplantation; Surgery; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.02397617729043418,"gpt":0.2398598868691217,"spread":0.2158837095786875,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001460619,0.0005013889,0.001604002,0.00005491563,0.0001883524,0.00004916918,0.000270378,0.0004834789,0.00005308412],"category_scores_gemma":[0.0006059815,0.0001999483,0.0002607924,0.0001889816,0.0008428365,0.00006293483,0.00006583511,0.0004147076,0.000002967568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009023849,"about_ca_system_score_gemma":0.0002256843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000456233,"about_ca_topic_score_gemma":0.00005013894,"domain_scores_codex":[0.9974137,0.0001630033,0.0007619488,0.0008001383,0.0004462547,0.00041496],"domain_scores_gemma":[0.9953433,0.002361684,0.000695565,0.001264592,0.0002662141,0.0000686163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001652107,0.0007837223,0.8593471,0.0006031046,0.0004318914,0.0005223292,0.0002478349,4.062038e-7,0.000001778752,0.00002961184,0.136198,0.0001821559],"study_design_scores_gemma":[0.00514894,0.00329464,0.9766598,0.0006163393,0.001642934,0.0001039082,0.001339153,0.0000421113,0.000125416,0.0003135787,0.01026452,0.0004486051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9382521,0.004115708,0.0002136233,0.04967116,0.00008499219,0.006786588,0.0006369555,0.00005025882,0.0001885923],"genre_scores_gemma":[0.9785668,0.0007063397,0.0008119215,0.01547321,0.0001178503,0.001142453,0.002634609,0.00004170201,0.0005051178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1259334,"threshold_uncertainty_score":0.8153655,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095913486","doi":"10.3324/haematol.2010.025338","title":"Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Research Institute; Cancer Research Institute","keywords":"IGHV@; Internal medicine; Randomization; Oncology; Randomized controlled trial; Medicine; Beta-2 microglobulin; Chronic lymphocytic leukemia; Relative risk; Progression-free survival; Overall survival; Leukemia; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.05414269921170813,"gpt":0.3289752179945787,"spread":0.2748325187828706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008016501,0.0001889179,0.0004971537,0.0001437165,0.00008001316,0.00002912333,0.0002958136,0.0002247689,0.0002132398],"category_scores_gemma":[0.001466515,0.00009794925,0.0001439449,0.0003050336,0.0002037708,0.00005616893,0.00006316384,0.0003942884,0.00005907442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001250863,"about_ca_system_score_gemma":0.001410126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002174569,"about_ca_topic_score_gemma":0.003396504,"domain_scores_codex":[0.9980847,0.0001900465,0.0005085746,0.0003372389,0.0005433006,0.0003361749],"domain_scores_gemma":[0.9979793,0.0009052624,0.0002173214,0.0007218344,0.00008969337,0.00008655299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03095046,0.009695374,0.8912869,0.0008900875,0.0008777697,0.002072175,0.01417007,0.00005403287,0.0122393,0.02256815,0.001541256,0.01365444],"study_design_scores_gemma":[0.2259939,0.007051706,0.7320438,0.0001932449,0.0006987768,0.001185162,0.003130025,0.004398383,0.01712804,0.006817279,0.0008552144,0.0005044514],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958614,0.000107581,0.00006584454,0.0002794783,0.0002132517,0.002619808,0.000006874406,0.00004017664,0.0008056148],"genre_scores_gemma":[0.9992853,0.00008842473,0.0001225063,0.00003047862,0.00005785865,0.0002991319,0.00003699118,0.00001391083,0.0000653301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1950434,"threshold_uncertainty_score":0.3994254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016011302","doi":"10.3324/haematol.2009.011692","title":"Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medizinische Universität Graz; Austrian Science Fund; Karl-Franzens-Universität Graz; Deutsche Forschungsgemeinschaft; Stem Cell Network","keywords":"Mesenchymal stem cell; Senescence; Stromal cell; Biology; Cell biology; Cell culture; Cancer research; Cell growth; Bone marrow; Cell cycle; Cell; Immunology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03979426336179286,"gpt":0.3223655926632829,"spread":0.28257132930149,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002872488,0.0003227167,0.0007407697,0.0001752056,0.000205496,0.0000344252,0.0002675621,0.0005159904,0.001520313],"category_scores_gemma":[0.0004857413,0.0002157426,0.0001214635,0.0003822309,0.0002505087,0.00006140736,0.0002008735,0.00104212,0.0001022659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001091537,"about_ca_system_score_gemma":0.00006634921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000271531,"about_ca_topic_score_gemma":0.0004713284,"domain_scores_codex":[0.997384,0.0002491128,0.0003723052,0.0006980301,0.0006282594,0.0006682647],"domain_scores_gemma":[0.9982856,0.0002402926,0.0002407337,0.0006525288,0.0002313158,0.0003495311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001025925,0.0006257781,0.04814108,0.00007693322,0.00003312345,0.0005962988,0.0003107247,0.000002768979,0.9467548,0.0003722346,0.002944559,0.00003917077],"study_design_scores_gemma":[0.001331256,0.000440746,0.2148142,0.0003032469,0.00003879689,0.000199879,0.001153349,0.0001397658,0.7801652,0.0006318737,0.0004918118,0.0002898774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925623,0.0001219329,0.00004401632,0.003120819,0.0001597415,0.001014721,0.00007908407,0.0001400509,0.002757312],"genre_scores_gemma":[0.9967466,0.0001355851,0.0005724611,0.0002443476,0.00007707887,0.0002176795,0.0001548094,0.00002713471,0.001824331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1666731,"threshold_uncertainty_score":0.9993924,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165746197","doi":"10.3324/haematol.2009.020636","title":"Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Haematologica","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Terry Fox Research Institute","funders":"National Health and Medical Research Council; Medical Research Council; Fondation de France","keywords":"Myeloid leukemia; Imatinib mesylate; Imatinib; microRNA; Medicine; Leukemia; TaqMan; Cancer research; Oncology; Real-time polymerase chain reaction; Internal medicine; Biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.008674175181232518,"gpt":0.2498548977066989,"spread":0.2411807225254664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003416444,0.0003712735,0.0007177147,0.0002644234,0.00009045773,0.00002638735,0.00024295,0.0002538818,0.0007917587],"category_scores_gemma":[0.000429921,0.0002578667,0.00008678312,0.0004642518,0.0001337478,0.00009188577,0.0001304472,0.0006155786,0.0008982752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001501344,"about_ca_system_score_gemma":0.000942663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001073822,"about_ca_topic_score_gemma":0.000263912,"domain_scores_codex":[0.9977083,0.0001064502,0.0004775983,0.000626482,0.000399785,0.0006813671],"domain_scores_gemma":[0.9983498,0.0001953264,0.0001495477,0.0008629445,0.00011795,0.0003244049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03095866,0.001323434,0.8375561,0.0003672579,0.0002939801,0.002798487,0.001371851,0.00005207232,0.1035069,0.000321364,0.004370122,0.01707971],"study_design_scores_gemma":[0.01415389,0.00217783,0.953715,0.0002992223,0.00007236721,0.0002697417,0.00002752967,0.00004901888,0.02088432,0.00004951924,0.007898018,0.0004035471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951954,0.00006966059,0.00001161388,0.0009378324,0.0001668257,0.001432459,0.00001712658,0.0001579734,0.002011107],"genre_scores_gemma":[0.9914382,0.0000083014,0.006944236,0.0005386937,0.00004730157,0.000155749,0.00004832026,0.00005105479,0.0007681968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1161589,"threshold_uncertainty_score":0.9999874,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106429556","doi":"10.3324/haematol.2012.076349","title":"Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study","year":2013,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Blood Services; Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Chugai Pharmaceutical; Merck Sharp and Dohme; IC Design Education Center; Astellas Pharma; Eisai; Genentech; CellGenix; Bayer HealthCare; Otsuka America; American Society for Blood and Marrow Transplantation; National Institutes of Health; BioMarin Pharmaceutical; Kiadis Pharma; Therakos; Les Laboratories Pierre Fabre; WellPoint; Teva Pharmaceutical Industries; HistoGenetics; Medical College of Wisconsin; StemCyte; Sanofi; Enzon Pharmaceuticals; Alexion Pharmaceuticals; Health Resources and Services Administration; Viropharma; U.S. Navy; Centers for Disease Control and Prevention; Osiris Therapeutics; Celgene; Pfizer; Biogen; Baxter International; U.S. Public Health Service; U.S. Department of Defense; U.S. Department of Health and Human Services; Astellas Pharma US; National Research Foundation; Otsuka America Pharmaceutical; Amgen; Blue Cross and Blue Shield Association; Be The Match Foundation; National Cancer Institute; Gilead Sciences","keywords":"Transplantation; Medicine; Population; Hematopoietic stem cell transplantation; Leukemia; Myelodysplastic syndromes; Stem cell; Hematopoietic stem cell; Internal medicine; Immunology; Haematopoiesis; Environmental health; Bone marrow; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1839209497776282,"gpt":0.3623463507827868,"spread":0.1784254010051586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002342933,0.0001900611,0.000623779,0.0001301591,0.0000428265,0.0000299512,0.00005231422,0.00009245097,0.00009117576],"category_scores_gemma":[0.00002797159,0.0001443113,0.00003663529,0.0003626523,0.0001878091,0.0002252709,0.00001392454,0.00009494407,0.000006925023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001835407,"about_ca_system_score_gemma":0.00002930246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002985473,"about_ca_topic_score_gemma":0.0001094782,"domain_scores_codex":[0.9983414,0.0003021063,0.0005629426,0.0003293992,0.0002863879,0.0001777298],"domain_scores_gemma":[0.9986049,0.0008925503,0.0001588229,0.0001247728,0.0001236311,0.00009532503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003090289,0.0005633915,0.9272171,0.0009508267,0.00005528312,0.0001280935,0.06197751,8.772118e-7,0.0004875431,0.007959306,0.00001884341,0.0003322576],"study_design_scores_gemma":[0.002073399,0.000921504,0.9489692,0.0002261273,0.0001077446,0.0002514974,0.04579653,0.0001757724,0.000438766,0.0009001436,6.199419e-7,0.0001387374],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997695,0.0002492656,0.0004176319,0.0003437439,0.00002163174,0.000714687,0.00004199804,0.00002728339,0.0004887247],"genre_scores_gemma":[0.9964283,0.000104711,0.003202263,0.00004872957,0.000002661614,0.0001155428,0.00002201001,0.000007214673,0.00006860462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02175212,"threshold_uncertainty_score":0.5884846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110993734","doi":"10.3324/haematol.2009.010306","title":"Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia","year":2009,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Australian Government","keywords":"CD20; Medicine; Cumulative incidence; Internal medicine; White blood cell; Rituximab; Lymphoblastic Leukemia; Oncology; Philadelphia chromosome; Incidence (geometry); Acute lymphocytic leukemia; Immunology; Leukemia; Gastroenterology; Lymphoma; Biology; Gene; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.01202314726519713,"gpt":0.2584060356743247,"spread":0.2463828884091276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002000799,0.0004656592,0.001086214,0.000327344,0.00007996039,0.00001201483,0.000388528,0.0003251697,0.0001801881],"category_scores_gemma":[0.0006597181,0.0003164855,0.0001289379,0.0009585421,0.0004589876,0.0001974001,0.0001015118,0.0004530548,0.000105578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008695675,"about_ca_system_score_gemma":0.001466042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003725089,"about_ca_topic_score_gemma":0.00001364297,"domain_scores_codex":[0.9965777,0.0001677005,0.000741717,0.0008337154,0.0008718577,0.0008072866],"domain_scores_gemma":[0.997592,0.0007303613,0.0004008093,0.0006360522,0.0003053496,0.0003353764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1298528,0.01516332,0.08004477,0.01104837,0.0009872122,0.05183138,0.01919072,0.003357716,0.6635469,0.001493545,0.01802995,0.005453321],"study_design_scores_gemma":[0.05381077,0.01808985,0.1301591,0.01409174,0.0006615277,0.003440142,0.002274614,0.0111569,0.7634215,0.001116051,0.0001902557,0.001587525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914454,0.0002024945,0.00081988,0.0006674784,0.00004632088,0.002564586,0.00003762334,0.0001517046,0.004064528],"genre_scores_gemma":[0.9914268,0.0001183426,0.007660215,0.0002159158,0.0000480351,0.0002349486,0.00003872674,0.00003992926,0.0002170667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09987463,"threshold_uncertainty_score":0.9999287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3000359647","doi":"10.3324/haematol.2019.239160","title":"Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Skånes universitetssjukhus; Medizinische Universität Wien; Hospital for Sick Children; Great Ormond Street Hospital for Children; Lunds Universitet; Institut National de la Recherche Agronomique; Institut National de la Santé et de la Recherche Médicale; University of Bern; Universität Wien; Helsingin Yliopisto","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Internal medicine; Prospective cohort study; Cohort; Gastroenterology; Missense mutation; Haemophilia; Pediatrics; Mutation; Biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02725189121489065,"gpt":0.2897221653766267,"spread":0.262470274161736,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001413389,0.0002219563,0.0007114416,0.0001200208,0.00004952189,0.00001233255,0.000155638,0.0001162607,0.0001399995],"category_scores_gemma":[0.0002625748,0.0001369902,0.00004114358,0.000829549,0.0001132482,0.00008146834,0.00006900382,0.0002403704,0.00002722585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004978052,"about_ca_system_score_gemma":0.0001730825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009090164,"about_ca_topic_score_gemma":0.0001712657,"domain_scores_codex":[0.998012,0.0002084884,0.0003972981,0.0004888679,0.0005451434,0.0003481972],"domain_scores_gemma":[0.9989266,0.00006265241,0.0001078385,0.0003221441,0.0002997674,0.0002809544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002363412,0.002387348,0.9916772,0.000130077,0.0000974651,0.000962547,0.001744824,0.00000489782,0.0001414586,0.000005320638,0.0001779662,0.0003074481],"study_design_scores_gemma":[0.005542958,0.01151752,0.9810612,0.0001556968,0.0001139905,0.00005025512,0.0003665161,0.0001194489,0.0008919121,0.000009128196,0.00001420316,0.0001572181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962722,0.00006304497,0.000001644676,0.0003868788,0.00001096359,0.002903488,0.000009544095,0.00008440253,0.0002678313],"genre_scores_gemma":[0.9993582,0.00001387001,0.0001936252,0.000115629,0.00002048403,0.00009002466,0.0001293603,0.00002174414,0.00005710883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01061608,"threshold_uncertainty_score":0.5586299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057046347","doi":"10.3324/haematol.2012.071068","title":"Mutations in the telomere capping complex in bone marrow failure and related syndromes","year":2012,"lang":"en","type":"article","venue":"Haematologica","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Wellcome Trust","keywords":"Dyskeratosis congenita; Telomere; Phenotype; Biology; Telomere-binding protein; Genetics; Mutation; Bone marrow failure; Shelterin; DNA; Gene; Stem cell; Haematopoiesis","retraction":null,"screen_n_in":null,"score":{"opus":0.04760938936269726,"gpt":0.2877051440021218,"spread":0.2400957546394246,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004835289,0.0001581313,0.0004333841,0.0001919679,0.00009905153,0.00001949449,0.0001642503,0.0001398117,0.0001813584],"category_scores_gemma":[0.0003004184,0.0001027107,0.00003303814,0.0005485192,0.0001843134,0.000159524,0.00007335014,0.0003376172,0.00004815177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000250539,"about_ca_system_score_gemma":0.00002928782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001171854,"about_ca_topic_score_gemma":0.0001970805,"domain_scores_codex":[0.9986175,0.0001590113,0.0003725977,0.0002594191,0.0001884702,0.0004029702],"domain_scores_gemma":[0.9991312,0.0002633859,0.00008107012,0.0004055225,0.0000237481,0.00009509485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007153393,0.0006341665,0.9625403,0.0003872137,0.0000546593,0.003043229,0.01325534,0.000004934569,0.002608324,0.008701094,0.004695076,0.004004103],"study_design_scores_gemma":[0.00112286,0.00006612756,0.9737718,0.0002193391,0.00004719827,0.009862009,0.008757048,0.0003489157,0.00006341087,0.0006793781,0.004846648,0.0002152842],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867145,0.003277859,0.000005029803,0.006844833,0.0000533221,0.0004419092,0.000006754197,0.00006118703,0.002594622],"genre_scores_gemma":[0.9981599,0.0001163725,0.001013053,0.0004828548,0.00001911046,0.00003012734,0.00005692351,0.00001102204,0.0001106023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01144545,"threshold_uncertainty_score":0.4188422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}